Avicanna Inc. AVCNF AVCN (ESF: 0NN) will expand its RHO Phyto form in Canada with Cannabigerol (“CBG”) on channels for medical and adult use across Canada.
Avicanna expands its RHO Phyto brand to include various CBG formulations that will be made available through various medical cannabis channels, such as Medical Cannabis by Shoppers and adult use channels, from its two listings in the cannabis store in Ontario in 3Q 2022.
As the Canadian cannabis market continues to expand, Avicanna is leveraging its R&D capabilities to deliver differentiated medical and wellness products, including rare cannabinoid formulations in established commercial channels. Initial CBG formulations will include:
RHO Phyto Rapid Act THC: CBG Spray: A combination of THC and CBG in a lemon and mint flavored spray that uses Avicanna’s sublingual delivery technology to provide a quick start.
RHO Phyto Micro Drop THC: CBG: CBD Oil: A combination of THC, CBG and CBD in a blood orange flavored oil that uses Avicanna’s inverted emulsion technology to provide better absorption and shelf life stability.
RHO Phyto CBG Transdermal Relief Gel: A combination of CBG and CBD in a fast-absorbing water-based gel. The gel uses Avicanna’s proven deep tissue technology and combines cannabinoids with synergistic natural ingredients and terpenes such as menthol and beta-caryophyllene.
Photo: courtesy of Thiago Patriota at Unsplash
Related news
EXCLUSIVE: How Avicanna is advancing in plant-derived and cannabinoid-based products
Breaking: Avicanna’s cannabinoid drugs to reach Brazil through first Big Pharma deal
Avicanna’s Derma-Cosmetics CBD will reach the European Union market through the Bio-Gate partnership
No related posts.
![My Experience with CBD Oil Rub for Chronic Pain and Inflammation [CC]](https://i.ytimg.com/vi/si25beRdFUA/hqdefault.jpg "My Experience with CBD Oil Rub for Chronic Pain and Inflammation [CC]")
